UnclassifiedBacteria/virusAnnounced September 4, 2026
Foods Alive — Moringa Leaf Powder
Potential to be contaminated with Salmonella
Read FDA’s announcement (opens in a new tab)Recalls affecting Mississippi
Data last updated: September 6, 2026 at 10:21 PM UTC
16,572 recalls foundJust announced
Straight from FDA press releases — not yet formally classified or risk-gradedUnclassifiedAnnounced September 4, 2026
Business Pill, Branch Manager for Men — dietary supplements marketed for male sexual enhancement
Products contain undeclared yohimbine
Read FDA’s announcement (opens in a new tab)UnclassifiedBacteria/virusAnnounced September 3, 2026
Great Value — Organic Triple Berry Blend
Possible E. Coli Contamination
Read FDA’s announcement (opens in a new tab)UnclassifiedAnnounced September 3, 2026
B. Braun — 0.9% Sodium Chloride Injection USP, 100 mL, in a 150 mL PAB® Container
Presence of particulate matter identified as iron oxide
Read FDA’s announcement (opens in a new tab)UnclassifiedAnnounced September 3, 2026
American Regent, Inc. — Epinephrine Injection, USP 30 mg/ 30 mL (1 mg/mL) multi dose vial
Presence of particulate matter and lack of sterility assurance
Read FDA’s announcement (opens in a new tab)UnclassifiedAnnounced August 31, 2026
Kofinas — Garlic Mediterranean Infused Extra Virgin Olive Oil 500 ml, 250 ml, and 100 ml
Contains garlic essential oil not approved for culinary use
Read FDA’s announcement (opens in a new tab)UnclassifiedAnnounced August 31, 2026
Lipofit — Lipofit Extreme 2.0 Fat Burner Dietary Supplement
Undeclared Fluoxetine and 2,4-Dinitrophenol (DNP)
Read FDA’s announcement (opens in a new tab)UnclassifiedAllergenAnnounced August 31, 2026
Little Temptations — Chocolatey Eyeballs, 7 oz., 10 oz., 10.5 oz., 11 oz., and 16 oz.
Undeclared milk
Read FDA’s announcement (opens in a new tab)UnclassifiedBacteria/virusAnnounced August 29, 2026
Everything Sprouts — Robust Radish Mix, 5oz Cups
Potential to be contaminated with Shiga toxin-producing Escherichia coli (STEC) or Salmonella.
Read FDA’s announcement (opens in a new tab)UnclassifiedBacteria/virusAnnounced August 29, 2026
Martina — Mangoes
Potential contamination with Salmonella
Read FDA’s announcement (opens in a new tab)Class IIModerate risk
DrugRecalled August 3, 2026
SILDENAFIL CITRATE USP, 1.00KG, 1.00KG-bag Net Wt. Rx only " For Prescription Compounding Only", Shoolin Pharma Chem LLP, Block/Survey no 408, B/H Ratnamani Tubes, Near Maruti Inox, Indrad, Kadi, Mahesania, Gujarat, 382715, India, (CAS NO. 171599-83-0) NDC 85702-001-08.
CGMP Deviations:Noted during FDA inspection
ALL 50 STATES
▸Full report
A moderate-risk recall. Using this product might cause temporary or reversible health problems, and serious harm is unlikely.
- Recall #:
- D-0763-2026
- Lot/product code:
- Lot: SDC2505001, Date of Expiry: April 30, 2030.
- Recalling firm:
- Shoolin Pharma Chem LLP
Class IIModerate risk
DrugRecalled August 3, 2026
TADALAFIL USP, 1.00 KG, 1KG(1000gm)-bag, Rx only, "For Prescription Compounding Only", Shoolin Pharma Chem LLP, Block/Survey no 408, B/H Ratnamani Tubes, Near Maruti Inox, Indrad, Kadi, Mahesania, Gujarat, 382715, India, (CAS NO 171596-29-5), NDC 85702-001-08
CGMP Deviations:Noted during FDA inspection
ALL 50 STATES
▸Full report
A moderate-risk recall. Using this product might cause temporary or reversible health problems, and serious harm is unlikely.
- Recall #:
- D-0762-2026
- Lot/product code:
- Batch TLF2506001, Date of Expiry: May 31, 2028.
- Recalling firm:
- Shoolin Pharma Chem LLP
UnclassifiedRisk not yet known
Medical deviceRecalled July 31, 2026
HEALON EndoCoat PRO, REF: 10300012 (US/CAN) HEALON DUET PRO II, REF: 10300016 (US/CAN) HEALON EndoCoat PRO, REF: 10301012 (EU); HEALON DUET PRO II, REF: 10301016 (EU)
Surgical instructions sent for viscoelastic products used during ophthalmic viscosurgical cataract procedures including in part: If resistance is encountered during insertion, withdraw cannula and reassess the insertion conditions (i.e. insertion angle, incision size, etc.) before proceeding because forcing the cannula may cause corneal abrasion, iris trauma or descemet's membrane detachment.
ALL 50 STATES
▸Full report
FDA has not published a risk classification for this recall yet.
- Recall #:
- 99496
- Lot/product code:
- REF/UDI-DI/Lot: 10300012/5050474755093/UA32232, UA32250, UA32268, UA32290, UA32292, UA32303, UA32371, UP31203, UP31205; 10300016/5050474755116/UA32447, UA32448, UA32449, UB33008, UB33026, UB33082, UB33083, UB33175; 10301012/5050474755109/UB33014, UB33041, UB33057, UB33060, UB33100, UB33190; 10301016/5050474755123/UB33084, UB33194
- Recalling firm:
- Johnson & Johnson Surgical Vision, Inc.
Class IHigh risk
DrugRecalled July 31, 2026
Optiray Imaging Bulk Package-350, Ioversol Injection 74%, 350 mg/mL Organically Bound Iodine, 500 mL Multiple-Dose Vial, Rx only, Sterile Solution, Manufactured by: Liebel-Flarsheim Company LLC, Raleigh, NC 27616, Made in USA, NDC 0019-1333-65.
Presence of Particulate Matter: comprising polyethylene and other plastic materials, stainless steel and glass.
ALL 50 STATES
▸Full report
The most serious kind of recall. Using this product could cause serious health problems or death.
- Recall #:
- D-0773-2026
- Lot/product code:
- Lot # 25ZF3670, Exp Date: May 31, 2027.
- Recalling firm:
- Liebel-Flarsheim Company LLC
Class IIModerate risk
DrugRecalled July 30, 2026
CLINDAMYCIN PALMITATE HYDROCHLORIDE FOR ORAL SOLUTION, USP, 75 mg/5 mL, Rx Only, 100 mL, Distributed by: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816, NDC 23155-603-51
Presence of Foreign Substance: presence of particles and white flakes in the reconstituted bottles.
ALL 50 STATES
▸Full report
A moderate-risk recall. Using this product might cause temporary or reversible health problems, and serious harm is unlikely.
- Recall #:
- D-0768-2026
- Lot/product code:
- Lot #: 2411550, Exp. 2026/NOV.
- Recalling firm:
- Heritage Pharmaceuticals Inc
UnclassifiedRisk not yet known
Medical deviceRecalled July 30, 2026
BD Needle Kit for Powered Driver 15mm x 15Ga, REF: D015151NK, BD Needle Kit for Powered Driver 25mm x 15Ga, REF: D015251NK, BD Needle Kit for Powered Driver 35mm x 15Ga, REF: D015351NK, BD Needle Kit for Powered Driver 45mm x 15Ga, REF: D015451NK, BD Needle Kit for Powered Driver 55mm x 15Ga, REF: D015551NK
After placement of intraosseous (IO) needle sets, used when intravenous access is difficult or impossible to obtain in emergent, urgent, or medically necessary cases, users may experience difficulty/inability to remove obturator, due to it locking to the needle hub, due to out-of-tolerance dimensions and IFU unclarity, which may result in new needle placement, which may result in delayed therapy
▸Full report
FDA has not published a risk classification for this recall yet.
- Recall #:
- 99484
- Lot/product code:
- REF/UDI-DI/Lot(Expiration): D015151NK/00801741163586/BSLC9275(2026-08-03), BSLC9563(2026-08-13), BSLC9567(2026-08-25), BSLC10103(2026-09-27), BSLC10516(2026-11-01), BSLC10526(2026-11-16), BSLC10872(2026-12-09), BSLC11216(2028-07-02), BSLC11456(2028-07-23); D015251NK/00801741163678/BSLC9467(2026-08-10), BSLC9575(2026-09-20), BSLC10105(2026-10-04), BSLC10522(2026-11-07), BSLC10868(2026-12-02), BSLC11212(2028-06-18), BSLC11454(2028-07-17), BSLC11463(2028-08-07), BSLC11884(2028-09-15), BSLC11890(2028-09-18), BSLC12082(2028-10-08), BSLC12115(2028-10-20), BSLC12123(2028-10-22); D015351NK/00801741163593/BSLC11458(2028-07-24); 00801741163678/BSLC9277(2026-08-04), BSLC9485(2026-08-12), BSLC9569(2026-08-26), BSLC10099(2026-09-07), BSLC10514(2026-10-16), BSLC10518(2026-10-21), BSLC10524(2026-11-08), BSLC10870(2026-12-03), BSLC10874(2028-06-12), BSLC11218(2028-07-07); D015451NK/00801741163609/BSLC9279(2026-08-06), BSLC9565(2026-08-17), BSLC9571(2026-09-07), BSLC10101(2026-09-17), BSLC10456(2026-10-14), BSLC10520(2026-10-22), BSLC10866(2026-11-21), BSLC11214(2028-06-23), BSLC11450(2028-07-09), BSLC11460(2028-07-31), BSLC11873(2028-08-13), BSLC11888(2028-09-25), BSLC12007(2028-10-02), BSLC12105(2028-10-15); D015551NK/00801741163616/BSLC9465(2026-08-07), BSLC9573(2026-09-26), BSLC10107(2026-10-02), BSLC10528(2026-11-20), BSLC11452(2028-07-10)
- Recalling firm:
- Bard Access Systems, Inc.
Class IIModerate risk
DrugRecalled July 29, 2026
SEMAGLUTIDE 9mg (4.5 mg/mL), 2 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-822-02
Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material
ALL 50 STATES
▸Full report
A moderate-risk recall. Using this product might cause temporary or reversible health problems, and serious harm is unlikely.
- Recall #:
- D-0751-2026
- Lot/product code:
- Lot: AC-017125, Exp. 8/30/2026; AC-017138, AC-017147, AC-017214, AC-017226, AC-017228, Exp. 12/31/2026.
- Recalling firm:
- Apollo Care, LLC
Class IIModerate risk
DrugRecalled July 29, 2026
SEMAGLUTIDE 12.5MG (2.5MG/mL), 5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-495-05
Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material
ALL 50 STATES
▸Full report
A moderate-risk recall. Using this product might cause temporary or reversible health problems, and serious harm is unlikely.
- Recall #:
- D-0747-2026
- Lot/product code:
- Lot: AC-017108, Exp. 11/17/2026; AC-017110, Exp. 11/20/2026; AC-017112, Exp. 11/21/2026; AC-017142, AC-017144, Exp. 12/10/2026; AC-017166, AC-017167, AC-017177, AC-017213, AC-017224, AC-017225, Exp. 12/31/2026
- Recalling firm:
- Apollo Care, LLC
UnclassifiedRisk not yet known
Medical deviceRecalled July 29, 2026
healthmark ProChek-II, Model Number PT-313, PT-201-12
Test manufactured with an expired ingredient which may present as either a false negative or positive.
ALL 50 STATES
▸Full report
FDA has not published a risk classification for this recall yet.
- Recall #:
- 99537
- Lot/product code:
- PT-313 - Serial/Lot Numbers: 3000535312, 3000535333, 3000536416, 3000536423, 3000537810, 3000537822, 3000542453, 3000545623, 3000550099, 3000550512, 313069, 313072, 313073, 313074, 313075, 313076, 313077, 313078, 313079, 313080, 313081, 313082, 313083, 313084, 313085, 313086, 313087, 313088, 313089, 313090, 313091, 313092, 313093, 313094, 313095, 313096, 313097, 313098, 313099, 313100, 313101, 313102, 313106, 313107; H-PT-201-12 - Serial/Lot Numbers: 7P0110, 7P0111, 7P0113, 7P0122.
- Recalling firm:
- Healthmark Industries Co., Inc.
UnclassifiedRisk not yet known
Medical deviceRecalled July 29, 2026
healthmark ProChek-W Protein Test for Robotic Arms; ProChek-Semi Quantitative Protein Test, Model Number PT-SQ-001
Test manufactured with an expired ingredient which may present as either a false negative or positive.
ALL 50 STATES
▸Full report
FDA has not published a risk classification for this recall yet.
- Recall #:
- 99537
- Lot/product code:
- Serial/Lot Numbers: 200035, 200036, 200037, 200038, 200039, 200040, 30028.
- Recalling firm:
- Healthmark Industries Co., Inc.
Class IIModerate risk
DrugRecalled July 29, 2026
CLEAR EYES Maximum Itchy Eye Relief, 0.5 fl oz (15 mL) per dropper bottle, Sterile, Dist. by Medtech Products Inc., Tarrytown, NY 10591, a Prestige Consumer Healthcare Company. NDC: 67172-999-01 UPC 6 78112 65920 3
Not guaranteed to be germ-free. The recall is due to potential contamination
ALL 50 STATES
▸Full report
A moderate-risk recall. Using this product might cause temporary or reversible health problems, and serious harm is unlikely.
- Recall #:
- D-0766-2026
- Lot/product code:
- Lot 2552A, Exp 09/30/2027
- Recalling firm:
- Prestige Brands Holdings
Class IIModerate risk
DrugRecalled July 29, 2026
SEMAGLUTIDE 6.75mg (4.5 mg/mL), 1.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202 NDC 71170-821-01
Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material
ALL 50 STATES
▸Full report
A moderate-risk recall. Using this product might cause temporary or reversible health problems, and serious harm is unlikely.
- Recall #:
- D-0749-2026
- Lot/product code:
- Lot: C-017115, Exp. 11/25/2026; AC-017163, Exp. 12/31/2026; AC-017169, AC-017170, AC-017171, Exp. 12/31/2026; AC-017230, AC-017231, Exp. 5/5/2027.
- Recalling firm:
- Apollo Care, LLC
Class IIModerate risk
DrugRecalled July 29, 2026
SEMAGLUTIDE 20mg (5mg/mL), Glycine 20 mg (5mg/mL), 4 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-724-04.
Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material
ALL 50 STATES
▸Full report
A moderate-risk recall. Using this product might cause temporary or reversible health problems, and serious harm is unlikely.
- Recall #:
- D-0757-2026
- Lot/product code:
- Lot: AC-017275, Exp. 12/13/2026; AC-017282, AC-017285, Exp. 12/27/2026.
- Recalling firm:
- Apollo Care, LLC
Class IIModerate risk
DrugRecalled July 29, 2026
SEMAGLUTIDE 2.25MG (0.9 mg/mL), 2.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202 NDC 71170-811-02
Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material
ALL 50 STATES
▸Full report
A moderate-risk recall. Using this product might cause temporary or reversible health problems, and serious harm is unlikely.
- Recall #:
- D-0748-2026
- Lot/product code:
- Lot: AC-017114, Exp. 11/24/2026; AC-017164, AC-017204, AC-017205, Exp. 12/31/2026.
- Recalling firm:
- Apollo Care, LLC
UnclassifiedRisk not yet known
Medical deviceRecalled July 29, 2026
STA Staclot Protein S, Model/Catalog Number: 00746-Reagent Lot number 273074; qualitative and quantitative factor deficiency test
A positive drift in QC values within the reagent's stated 4-hour onboard stability period was identified
ALL 50 STATES
▸Full report
FDA has not published a risk classification for this recall yet.
- Recall #:
- 99531
- Lot/product code:
- UDI : (01)3607450007466(11)250331(17)270331(10)273074(241)00746, Exp 3/31/2027
- Recalling firm:
- Diagnostica Stago, Inc.
Class IIModerate risk
DrugRecalled July 29, 2026
SEMAGLUTIDE 4.5mg (0.9 mg/mL), 5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-812-03
Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material
ALL 50 STATES
▸Full report
A moderate-risk recall. Using this product might cause temporary or reversible health problems, and serious harm is unlikely.
- Recall #:
- D-0750-2026
- Lot/product code:
- Lot: AC-017124, Exp. 8/30/2026; AC-017136, Exp. 12/31/2026.
- Recalling firm:
- Apollo Care, LLC
Class IIModerate risk
DrugRecalled July 29, 2026
SEMAGLUTIDE 5mg (1mg/mL), Glycine 25 mg (5mg/mL), 5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202.NDC 71170-712-03
Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material
ALL 50 STATES
▸Full report
A moderate-risk recall. Using this product might cause temporary or reversible health problems, and serious harm is unlikely.
- Recall #:
- D-0754-2026
- Lot/product code:
- Lot: AC-017272, Exp. 12/12/2026.
- Recalling firm:
- Apollo Care, LLC
Class IIModerate risk
DrugRecalled July 29, 2026
SEMAGLUTIDE 7.5mg (5mg/mL), Glycine 7.5 mg (5mg/mL), 1.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-721-01
Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material
ALL 50 STATES
▸Full report
A moderate-risk recall. Using this product might cause temporary or reversible health problems, and serious harm is unlikely.
- Recall #:
- D-0755-2026
- Lot/product code:
- Lot: AC-017273, Exp. 12/12/2026.
- Recalling firm:
- Apollo Care, LLC
Class IIModerate risk
DrugRecalled July 29, 2026
SEMAGLUTIDE 10mg (5mg/mL), Glycine 10 mg (5mg/mL), 2 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-722-02
Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material
ALL 50 STATES
▸Full report
A moderate-risk recall. Using this product might cause temporary or reversible health problems, and serious harm is unlikely.
- Recall #:
- D-0756-2026
- Lot/product code:
- Lot: AC-017274, Exp. 12/12/2026.
- Recalling firm:
- Apollo Care, LLC
Class IIModerate risk
DrugRecalled July 29, 2026
SEMAGLUTIDE 2.5mg (1mg/mL), Glycine 12.5 mg (5mg/mL), 2.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-711-02
Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material
ALL 50 STATES
▸Full report
A moderate-risk recall. Using this product might cause temporary or reversible health problems, and serious harm is unlikely.
- Recall #:
- D-0753-2026
- Lot/product code:
- Lot: AC-017271, Exp. 12/12/2026.
- Recalling firm:
- Apollo Care, LLC
Class IIModerate risk
DrugRecalled July 29, 2026
SEMAGLUTIDE 0.9mg (0.9 mg/mL), 1 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-810-01
Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material
ALL 50 STATES
▸Full report
A moderate-risk recall. Using this product might cause temporary or reversible health problems, and serious harm is unlikely.
- Recall #:
- D-0752-2026
- Lot/product code:
- Lot: AC-017131, Exp. 8/30/2026.
- Recalling firm:
- Apollo Care, LLC
UnclassifiedRisk not yet known
Medical deviceRecalled July 24, 2026
Ami HTX
Momentary absence of On-Screen "X-Ray On" banner during run readiness check.
ALL 50 STATES
▸Full report
FDA has not published a risk classification for this recall yet.
- Recall #:
- 99631
- Lot/product code:
- All serial numbers.
- Recalling firm:
- Spectral Instruments Inc
UnclassifiedRisk not yet known
Medical deviceRecalled July 24, 2026
Lago X
Momentary absence of On-Screen "X-Ray On" banner during run readiness check.
ALL 50 STATES
▸Full report
FDA has not published a risk classification for this recall yet.
- Recall #:
- 99631
- Lot/product code:
- All serial numbers.
- Recalling firm:
- Spectral Instruments Inc
Not Yet ClassifiedRisk not yet known
DrugRecalled July 24, 2026
Cefazolin in Dextrose, Injection, USP, 2g / 100mL (20mg / mL) Single-Dose Infusion Bag in 100mL GALAXY Plastic Container, Frozen Premix, Sterile, Rx only, Manufactured by Baxter Healthcare Corporation, Deerfield, IL 60015, USA, NDC 0338-3508-41.
Presence of Particulate Matter
ALL 50 STATES
▸Full report
FDA has not published a risk classification for this recall yet.
- Recall #:
- Lot/product code:
- Lot # LD175708, Exp Date: 14-Feb-2027.
- Recalling firm:
- Baxter Healthcare Corporation
Class IIModerate risk
FoodRecalled July 24, 2026
Big Way Hot Pot "Hot Pot Miso Paste"; 1kg (35.3oz) unit package. Product is packaged in generic bulk packaging.
Not listed on the label milk from lactose.
ALL 50 STATES
▸Full report
A moderate-risk recall. Using this product might cause temporary or reversible health problems, and serious harm is unlikely.
- Recall #:
- H-1195-2026
- Lot/product code:
- Item No. CKJ19067 Lot: 20251106Z1-1 Expiration: NOV/05/2026
- Recalling firm:
- Big Way Ca Inc